Research Article
Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome
Table 4
Positive aPL antibodies in PAPS versus SAD-APS patients.
| | Antibody | PAPS () | SAD-APS () | OR SAD-APS | |
| | aB2GPI IgG | 3 (2.1%) | 11 (73.3%) | 126.5 | <0.0001 | | aB2GPI IgM | 5 (3.5%) | 3 (20%) | 6.8 | 0.0331 | | aB2GPI IgA | 36 (21.9%) | 9 (60%) | 4.4 | 0.0124 | | aCL IgG | 6 (4.2%) | 11 (73.3%) | 61.9 | <0.0001 | | aCL IgM | 5 (3.5%) | 3 (20%) | 6.8 | 0.0331 | | aCL IgA | 4 (2.8%) | 4 (26.7%) | 12.4 | 0.0008 | | aB2GP1 IgA (isolated) | 33 (23.4%) | 2 (13.3%) | 0.5 | 0.5732 | | aCL or aB2GPI (IgG or IgM) | 11 (7.8%) | 11 (73.3%) | 32.5 | <0.0001 | | aCL or aB2GPI any isotype | 47 (33.3%) | 14 (93.3%) | 28.0 | <0.0001 |
|
|
